Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589745 · ClinicalTrials.gov registry record · NA
Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00589745 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 27 participants.
The verdict
NCT00589745, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this research study is to provide a novel method for the diagnosis of Cystic Fibrosis (CF). This protocol is designed to test the ability of the cells to regulate the movement of salt and water in people with features of CF in whom the diagnosis is not entirely clear. We will be studying these cells in the nose, by a technique called nasal transepithelial potential difference (NPD).
Interventions
- OTHER Nasal potential difference measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2003-09 |
| Est. Completion | 2019-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589745
The ClinicalTrials.gov registry entry for NCT00589745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal potential difference measurement is the first listed.
NCT00589745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589745 about?
NCT00589745 is a clinical study titled "Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis". The purpose of this research study is to provide a novel method for the diagnosis of Cystic Fibrosis (CF). This protocol is designed to test the ability of the cells to regulate the movement of salt and water in people with features of CF in whom the diagnosis is not entirely clear. We will be study...
What is the current status of trial NCT00589745?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2003-09. Estimated completion is 2019-12-18.
What interventions are being tested in trial NCT00589745?
The interventions under investigation include: Nasal potential difference measurement (OTHER).
Who is sponsoring clinical trial NCT00589745?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.